View all results
No results
News
Events
The industry
arrow_drop_down
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Networking platforms
Newsletter
Association
arrow_drop_down
Mission and services
Members
Academy
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
CALY-002
Product
prev
next
Leave a review
Bookmark
Share
Report
prev
next
Indicaton
Celiac Disease, Eosinophilic Esophagitis, Dermatology
Therapeutic indications
Autoimmmune diseaese
Type of product
Antibody
Company
Calypso Biotech SA
Table
Phase
Phase I started
Partnering status
Not partnered
You may also be interested in
ENDO-APS
Anti-Beta 2 Glycoprotein I IgG (anti-β2GPI IgG) is a quantitative assay for determination of anti-β2GPI IgG antibodies relative to antiphospholipids syndrome (APS) in human serum or plasma. The ENDO-APS-HR assay is the only fully standardized and most sensitive ELISA for anti-β2GPI IgG available for human research.
Filing
Veblocema (infliximab SC)
Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis
Marketed
Remsima (infliximab IV)
Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis
Marketed
Cart
×
View all results
No results
Facebook
Twitter
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
VKontakte
Mail
Copy link
This site uses cookies:
Find out more.
Accept